This topic contains a solution. Click here to go to the answer

Author Question: Which of the following behaviors is not associated with the opportunistic leadership style? a. ... (Read 36 times)

tfester

  • Hero Member
  • *****
  • Posts: 534
Which of the following behaviors is not associated with the opportunistic leadership style?
 
  a. The leader shifts his or her style to gain personal advantage.
  b. The leader may be perceived as ruthless and cunning.
  c. The leader may be perceived as adaptable and strategic.
  d. The leader puts self-interest ahead of other-interest.
  e. The leader stresses the importance of social needs.

Question 2

In which way will leadership and power be approached in upcoming chapters?
 
  a. As a form of coercion.
  b. As positional power.
  c. From the perspective of the follower.
  d. As a relational concern for both leaders and followers.
  e. As a tool to be used by the leader.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

atrochim

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

E

Answer to Question 2

D




tfester

  • Member
  • Posts: 534
Reply 2 on: Jul 8, 2018
YES! Correct, THANKS for helping me on my review


bigsis44

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library